SHOC2 and liver cancer: However, in an in vivo liver cancer model induced by Pten-loss with mTorc activation, Shoc2 acts as a tumor suppressor, since its deletion further activates the mTorc1 signal to promote liver tumorigenesis (Fig. 7).